ChinaSavvy lands $1.3 million engineering contract to supply components for high-tech storage systems
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies.
ChinaSavvy is in receipt of a USD 1.3 million order to supply components for high-tech robotic storage systems by Hamilton Storage, a global company with headquarters in Massachusetts, US.
ChinaSavvy is a British owned and managed engineering and manufacturing company based in China. The company, founded in 2003, was established with the primary aim of delivering world-class engineering and manufacturing services to blue-chip companies in the US, UK, Australia and many other countries around the globe, while taking advantage of low Chinese manufacturing costs.
In the bid to achieve world-class engineering in China, Chinasavvy, an ISO 9001-2008 company, recruited highly qualified engineers and tech veterans and coupled them with state-of-the-art technology in the engineering and manufacturing industry. The company has earned a global reputation in the delivery of high quality, world-class engineering and manufacturing services at affordable prices. ChinaSavvy’s customer base is extremely loyal with companies continuing to rely on Chinasavvy for engineering and manufacturing after 10 to 12 years. And Hamilton has already indicated a long-term commitment to Chinasavvy for further components and systems.
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies. Hamilton Storage, part of the Hamilton group, has operations world-wide and are leaders in this field.
Christopher Devereux, the Managing Director of ChinaSavvy said: “We are committed to ensuring that we deliver exceptional world-class engineering and manufacturing services to Hamilton Storage, to cement the business partnership and prove to them that they have taken the right business decision. Once again we have shown that ‘China pricing’ can go hand in hand with exceptional quality and on-time deliveries. For this order we are combining various manufacturing skills including: aluminium extrusion and punching; laser cutting, die-casting; injection moulding; fabrication and assembly.”
Dave Recchia, Head of Purchasing at Hamilton Storage said:, “Hamilton Storage conducted an extensive search for a new manufacturing partner last summer. During this search our purchasing team discovered ChinaSavvy. It became evident very quickly during the quoting process that ChinaSavvy was unique among other vendors in Asia. We were very impressed with the turnaround time on quotes, the ease of communication in English, and also the highly competitive pricing.”
John Genereux, Director of R&D at Hamilton Storage, added: “As initial work progresses we see ChinaSavvy’s commitment to our project and their deep focus on sound engineering and overall product quality. Hamilton Storage looks forward to a long productive partnership with ChinaSavvy and would recommend them to other companies looking for a highly competent partner in Asia.”
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance